Cite
Frequency and prognostic significance of hypercalcemia in patients with multiple myeloma
MLA
Kanar J Karim, et al. “Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma.” Medical Journal of Babylon, vol. 17, no. 4, Jan. 2020, pp. 327–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..b119c51b0e2251564e11aaa6ba59dd53&authtype=sso&custid=ns315887.
APA
Kanar J Karim, Abid M Hassan, Hisham A Getta, Najmaddin S. H. Khoshnaw, Sana D Jalal, Akram M Mohammed, Kawa M Hasan, Dana A Abdullah, Ameer I A. Badi, Ahmed K Yassin, Banaz M Safar, Basil K Abdulla, Rawand P Shamoon, Truska A Amin, Zeki A Mohamed, Ali I Mohammed, Diveen J Hussein, Nawsherwan S Mohammed, Rezhin N Rajab, & Firiad Hiwaizi. (2020). Frequency and prognostic significance of hypercalcemia in patients with multiple myeloma. Medical Journal of Babylon, 17(4), 327–331.
Chicago
Kanar J Karim, Abid M Hassan, Hisham A Getta, Najmaddin S. H. Khoshnaw, Sana D Jalal, Akram M Mohammed, Kawa M Hasan, et al. 2020. “Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma.” Medical Journal of Babylon 17 (4): 327–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..b119c51b0e2251564e11aaa6ba59dd53&authtype=sso&custid=ns315887.